Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-30

FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals Limited's supplemental application for a lamotrigine chewable dispersible formulation, adding this dosage form to the avail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine Chewable Dispersible (Lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE CHEWABLE DISPERSIBLE)